We have assembled an all-star panel of judges to hear your pitches, ask challenging questions and decide on winners for our three challenges! We will be announcing our full judging panel shortly but for now we are excited to welcome Michelle and Celia on-board!
Michelle is currently an Executive-in-Residence at InterWest Partners, focusing on the intersection of healthcare and technology. She is particularly passionate about the transformative role mobile, social, data, and consumers are beginning to play in the healthcare industry. She serves as a mentor to several of the most prominent accelerator programs and is an adviser to leading early stage digital health companies including Asthmapolis, WellTok, ShareTheVisit, and HealthLoop.
Prior to InterWest Partners, Michelle was one of the early employees at Epocrates and helped to build the company into one of the leading mobile health care information technology companies. During her tenure from launch to IPO, Michelle drove growth of the user network to more than 40% of U.S. physicians and developed one of the most successful freemium models in the industry. Prior to Epocrates, Michelle worked as a health strategy consultant with The Wilkerson Group, working with a range of clients including venture firms, pharmaceutical companies, and early stage companies. In addition, she has been involved in both health policy formation and implementation at the national level through her work at The Lewin Group and the Georgetown Center for Health Policy Studies.
Michelle earned her M.B.A. at the Kellogg School of Management at Northwestern University and her B.A. from Carleton College.
Celia Carter is currently the Business Manager for the Country Clinical Operations (CCO) organization at Genentech. CCO is comprised of over 1500 employees supporting local clinical trial and site monitoring activities in over 60 countries. In her role she serves as the Chief of Staff and provides strategic business management support and direction to the CCO organization and leadership team.
Prior to Genentech, Celia was the Director of Operations at United BioSource Corporation’s (UBC) clinical technology business unit, now Bracket. Bracket partners with life sciences organizations to design, develop and implement custom technology solutions to support their clinical trials and product commercialization. At UBC, Celia oversaw global operations and was accountable for all product deliverable activities and service commitments. As the Director of Operations she drove 30% year-to-year revenue growth and successfully prepared the business unit operationally and financially for acquisition by Medco Health Solutions (now Express Scripts).
Celia holds a B.A. degree from the University of California at Berkeley and is currently an Evening and Weekend MBA student at the University of California at Berkeley, Haas School of Business.
Founder & President
Roman Giverts is the Founder and President of VuMedi, the YouTube for surgeons. Roman started VuMedi as an undergrad engineer at UC Berkeley, and bootstrapped the company from his college apartment. He subsequently raised angel funding from a group of elite physicians around the country. Roman has led the growth of VuMedi into one the largest communities of physicians in the world.
His passion is the art of bootstrapping: how to get your first users/customers, raise seed funding, and turn your idea into a company.
Liz Rockett is a Vice President at Imprint Capital and runs the Health practice, helping foundations and wealth managers make impact-focused investments to improve health and care quality, and reduce the burdens of care costs.
Liz’s experience spans the healthcare industry, leading software business lines at Outcome and the Advisory Board Company and serving as interim Director of the Health 2.0 Developer Challenge. She has worked within the TriZetto Group’s innovation group for aligning healthcare incentives, and Kaiser’s prevention and chronic care management teams at the Permanente Medical Group. Liz holds an undergraduate degree from Princeton University, and an MBA and an MPH from the University of California at Berkeley. She serves on the Haas Alumni Council, as a mentor for Springboard Enterprises and Startup Weekend, and as an advisor to several startups.
NSF Bay Area I-Corps program
Todd Morrill has been building and leading bioscience companies since the first biotech boom in the early 1980s. He has been employee number 500, number 10 and number 2 (several times) of venture-backed startups, as well as a founder of three companies. He spent seven years in investment banking for pharma and biotech, and has worked at multinational pharma, diagnostics and tools companies. His roles have included sales, product management, marketing, R&D, business development and CEO. He has been an independent Board member of three companies.
Todd taught at the Haas School of Business, UC Berkeley from 2001 to 2009, where he is a Richard C. Holton Teaching Fellow. His courses included Entrepreneurship in Biotechnology; Mergers and Acquisitions; and Entrepreneurship. He has taught in the Intel Program in China and Japan, the Malaysia/UCSF program, and in biotech programs in Estonia, Australia and Abu Dhabi. Todd received an MBA from Haas and his BA in Biology, with Highest Honors, from Dartmouth College. He is an internationally-recognized author of many emails, has received almost one Olympic medal, and a comparable number of Nobel nominations. He is an avid user of social interaction; his teenagers make fun of him on Facebook and his wife makes fun of him in French. He returned to teaching in 2013 because of his excitement with the NSF Innovation Corps (I-Corps) program.